Prognostic values of modifiable risk factors for cardiovascular events in South African health promotion.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
04
2021
accepted:
24
06
2022
entrez:
10
8
2022
pubmed:
11
8
2022
medline:
13
8
2022
Statut:
epublish
Résumé
Cardiovascular diseases (CVDs) are increasing at an alarming rate among the South African population. This study aimed to determine the prognostic value of modifiable CVD risk factors for fatal and non-fatal events to inform cardiovascular health promotion practices in the South African public health system. Data was collected from individuals participating in the South African leg of a multi-national prospective cohort study. Binary logistic regression was applied to estimate odds of total, non-fatal and fatal cardiovascular events. Binary logistic regression analyses identified age as a predictor of non-fatal and fatal CV events, with ORs of 1.87 to 3.21, respectively. Hypertension increased the odd of suffering a non-fatal CV event by almost two and a half (OR = 2.47; 95% CI = 1.26, 4.85). Moreover, being physically active reduced the odd of non-fatal CVD events by 38% (OR = 0.62; 95% CI = 0.46, 0.83 for 1 Standard deviation increase of the weighted physical activity index score (WPA)). On the one hand, gamma-glutamyltransferase (GGT) was associated with a higher fatal cardiovascular disease risk OR = 2.45 (95% CI = 1.36, 4.42) for a standard deviation increase. Elevated blood pressure, GGT, and physical activity have significant prognostic values for fatal or non-fatal CV events. These findings emphasise the importance of highlighting hypertension and physical activity when planning cardiovascular health education and intervention programmes for this population, with attention to the monitoring of GGT.
Sections du résumé
BACKGROUND
Cardiovascular diseases (CVDs) are increasing at an alarming rate among the South African population. This study aimed to determine the prognostic value of modifiable CVD risk factors for fatal and non-fatal events to inform cardiovascular health promotion practices in the South African public health system.
METHODS
Data was collected from individuals participating in the South African leg of a multi-national prospective cohort study. Binary logistic regression was applied to estimate odds of total, non-fatal and fatal cardiovascular events.
RESULTS
Binary logistic regression analyses identified age as a predictor of non-fatal and fatal CV events, with ORs of 1.87 to 3.21, respectively. Hypertension increased the odd of suffering a non-fatal CV event by almost two and a half (OR = 2.47; 95% CI = 1.26, 4.85). Moreover, being physically active reduced the odd of non-fatal CVD events by 38% (OR = 0.62; 95% CI = 0.46, 0.83 for 1 Standard deviation increase of the weighted physical activity index score (WPA)). On the one hand, gamma-glutamyltransferase (GGT) was associated with a higher fatal cardiovascular disease risk OR = 2.45 (95% CI = 1.36, 4.42) for a standard deviation increase.
CONCLUSIONS
Elevated blood pressure, GGT, and physical activity have significant prognostic values for fatal or non-fatal CV events. These findings emphasise the importance of highlighting hypertension and physical activity when planning cardiovascular health education and intervention programmes for this population, with attention to the monitoring of GGT.
Identifiants
pubmed: 35947581
doi: 10.1371/journal.pone.0271169
pii: PONE-D-21-12357
pmc: PMC9365156
doi:
Substances chimiques
gamma-Glutamyltransferase
EC 2.3.2.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0271169Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Glob Health Action. 2018;11(sup2):1448250
pubmed: 30079826
BMC Public Health. 2020 May 12;20(1):665
pubmed: 32398061
Eur J Clin Invest. 2010 Jan;40(1):35-53
pubmed: 20055895
Int J Environ Res Public Health. 2017 Sep 20;14(9):
pubmed: 28930196
Prev Med. 2016 May;86:123-9
pubmed: 26923555
Cardiovasc J Afr. 2019 Jul/Aug 23;30(4):228-238
pubmed: 31361296
Ethn Dis. 2016 Oct 20;26(4):553-560
pubmed: 27773983
Glob Health Action. 2015 Oct 01;8:29003
pubmed: 26434691
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Lancet Glob Health. 2019 Feb;7(2):e270-e280
pubmed: 30528531
Clin Cardiol. 2015 Dec;38(12):747-56
pubmed: 26671071
Am Heart J. 2009 Jul;158(1):1-7.e1
pubmed: 19540385
Eur J Clin Invest. 2016 Nov;46(11):901-910
pubmed: 27600376
Circulation. 2016 Jun 14;133(24):2561-75
pubmed: 27297348
BMJ Glob Health. 2017 Aug 16;2(3):e000348
pubmed: 29082013
Circulation. 2019 Jul 9;140(2):e98-e124
pubmed: 31154814
Z Gesundh Wiss. 2015;23(3):129-136
pubmed: 26000232
J Am Heart Assoc. 2018 Sep 18;7(18):e009326
pubmed: 30371182
Cardiovasc J Afr. 2012 Aug;23(7):371-8, e379-88
pubmed: 22914994
J Epidemiol Community Health. 2015 Mar;69(3):218-25
pubmed: 25550454
BMC Public Health. 2017 May 10;17(1):424
pubmed: 28486934
Circ Cardiovasc Qual Outcomes. 2019 Feb;12(2):e004973
pubmed: 30760007
Sports Med Health Sci. 2019 Sep 10;1(1):3-10
pubmed: 35782456
BMC Public Health. 2017 Dec 15;17(1):954
pubmed: 29246206
N Engl J Med. 2019 Jul 18;381(3):243-251
pubmed: 31314968
Nat Rev Cardiol. 2017 May;14(5):273-293
pubmed: 28230175
Diabetes Res Clin Pract. 2018 Aug;142:312-320
pubmed: 29906479
Eur J Prev Cardiol. 2016 Feb;23(3):308-15
pubmed: 25500903
PLoS Comput Biol. 2019 Jun 24;15(6):e1007083
pubmed: 31233494
J Clin Hypertens (Greenwich). 2017 Nov;19(11):1181-1191
pubmed: 28895288
Afr Health Sci. 2020 Sep;20(3):1344-1354
pubmed: 33402984
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
J Clin Hypertens (Greenwich). 1999 Jul;1(1):48-54
pubmed: 11416593
BMJ. 2018 May 29;361:k934
pubmed: 29844013
Can J Cardiol. 2016 Nov;32(11):1263-1282
pubmed: 27712954
Public Health Nutr. 2020 Jun;23(9):1515-1526
pubmed: 32200768
Ann Hum Biol. 2018 Mar;45(2):123-132
pubmed: 29557678
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
S Afr Med J. 2015 Jan 07;105(2):110-4
pubmed: 26242528
J Health Popul Nutr. 2017 Nov 13;36(1):36
pubmed: 29132438
Int J Epidemiol. 2013 Dec;42(6):1754-71
pubmed: 24415610
J Hypertens. 2019 Aug;37(8):1606-1614
pubmed: 30950976
Int J Biol Sci. 2017 Oct 17;13(10):1320-1328
pubmed: 29104498
BMC Health Serv Res. 2018 Mar 22;18(1):197
pubmed: 29566692
Aging Ment Health. 2019 Aug;23(8):1000-1007
pubmed: 29781714
Lancet Glob Health. 2019 Oct;7(10):e1375-e1387
pubmed: 31537368
Aging Male. 2019 Sep;22(3):169-176
pubmed: 30879380
Glob Heart. 2020 Feb 12;15(1):15
pubmed: 32489788
Am J Clin Nutr. 1982 Nov;36(5):936-42
pubmed: 7137077
BMC Cardiovasc Disord. 2019 Aug 29;19(1):206
pubmed: 31464591
Eur J Prev Cardiol. 2016 Nov;23(16):1690-1699
pubmed: 27450159
J Clin Med. 2020 Jun 19;9(6):
pubmed: 32575540
Hum Antibodies. 2019;27(4):213-220
pubmed: 30958340